Other Species / Isoforms
  ARHGAP5 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S12-p
NKEPRPPsYTIsIVG
0 1
ARHGAP5 (human) NKEPRPPsYTIsIVG S12-p
ARHGAP5 iso2 (human) NKEPRPPSYTISIVG S12
ARHGAP5 (mouse) NKEPRPPSYTVSVVG S12
ARHGAP5 iso3 (mouse) NKEPRPPSYTVSVVG S12
ARHGAP5 (rat) NKEPRPPSYTVSVVG S11
S16-p
RPPsYTIsIVGLsGt
0 1
ARHGAP5 (human) RPPsYTIsIVGLsGt S16-p
ARHGAP5 iso2 (human) RPPSYTISIVGLSGT S16
ARHGAP5 (mouse) RPPSYTVSVVGLSGT S16
ARHGAP5 iso3 (mouse) RPPSYTVSVVGLSGT S16
ARHGAP5 (rat) RPPSYTVSVVGLSGT S15
S21-p
TIsIVGLsGtEKDKG
0 1
ARHGAP5 (human) TIsIVGLsGtEKDKG S21-p
ARHGAP5 iso2 (human) TISIVGLSGTEKDKG S21
ARHGAP5 (mouse) TVSVVGLSGTEKDKG S21
ARHGAP5 iso3 (mouse) TVSVVGLSGTEKDKG S21
ARHGAP5 (rat) TVSVVGLSGTEKDKG S20
T23-p
sIVGLsGtEKDKGNC
0 1
ARHGAP5 (human) sIVGLsGtEKDKGNC T23-p
ARHGAP5 iso2 (human) SIVGLSGTEKDKGNC T23
ARHGAP5 (mouse) SVVGLSGTEKDKGNC T23
ARHGAP5 iso3 (mouse) SVVGLSGTEKDKGNC T23
ARHGAP5 (rat) SVVGLSGTEKDKGNC T22
T199-p
KPVIIAAtKCDECVD
0 1
ARHGAP5 (human) KPVIIAAtKCDECVD T199-p
ARHGAP5 iso2 (human) KPVIIAATKCDECVD T199
ARHGAP5 (mouse) KPVIIAATKCDECVD T199
ARHGAP5 iso3 (mouse) KPVIIAATKCDECVD T199
ARHGAP5 (rat) KPVIIAATKCDECVD T198
K278
TATDKFEKLVQTVRD
0 1
ARHGAP5 (human) TATDKFEKLVQTVRD K278
ARHGAP5 iso2 (human) TATDKFEKLVQTVRD K278
ARHGAP5 (mouse) TATDKFEkLVQTVRD K278-ub
ARHGAP5 iso3 (mouse) TATDKFEKLVQTVRD K278
ARHGAP5 (rat) TATDKFEKLVQTVRD K277
T289-p
TVRDYHAtWKTVSNK
0 2
ARHGAP5 (human) TVRDYHAtWKTVSNK T289-p
ARHGAP5 iso2 (human) TVRDYHATWKTVSNK T289
ARHGAP5 (mouse) TVRDYHAtWKTVSNK T289-p
ARHGAP5 iso3 (mouse) TVRDYHATWKTVSNK T289
ARHGAP5 (rat) TVRDYHATWKTVSNK T288
Y306-p
NHPDYEEyINLEGTR
Upstream
Downstream
1 0
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell differentiation, altered
Kinase, in vitro:
  • INSR (human)
Treatment
  • IGF-1
ARHGAP5 (human) NHPDYEEyINLEGTR Y306-p
ARHGAP5 iso2 (human) NHPDYEEYINLEGTR Y306
ARHGAP5 (mouse) NHPDYEEYINLEGTR Y306
ARHGAP5 iso3 (mouse) NHPDYEEYINLEGTR Y306
ARHGAP5 (rat) NHPDYEEYINLEGTR Y305
K314-ac
INLEGTRkARNTFSk
0 1
ARHGAP5 (human) INLEGTRkARNTFSk K314-ac
ARHGAP5 iso2 (human) INLEGTRKARNTFSK K314
ARHGAP5 (mouse) INLEGTRKARNTFSK K314
ARHGAP5 iso3 (mouse) INLEGTRKARNTFSK K314
ARHGAP5 (rat) INLEGTRKARNTFSK K313
K321-ac
kARNTFSkHIEQLkQ
0 1
ARHGAP5 (human) kARNTFSkHIEQLkQ K321-ac
ARHGAP5 iso2 (human) KARNTFSKHIEQLKQ K321
ARHGAP5 (mouse) KARNTFSKHIEQLKQ K321
ARHGAP5 iso3 (mouse) KARNTFSKHIEQLKQ K321
ARHGAP5 (rat) KARNTFSKHIEQLKQ K320
K327-ub
SkHIEQLkQEHIRKR
0 1
ARHGAP5 (human) SkHIEQLkQEHIRKR K327-ub
ARHGAP5 iso2 (human) SKHIEQLKQEHIRKR K327
ARHGAP5 (mouse) SKHIEQLKQEHIRkR K327
ARHGAP5 iso3 (mouse) SKHIEQLKQEHIRKR K327
ARHGAP5 (rat) SKHIEQLKQEHIRKR K326
K333
LkQEHIRKRREEYIN
0 1
ARHGAP5 (human) LkQEHIRKRREEYIN K333
ARHGAP5 iso2 (human) LKQEHIRKRREEYIN K333
ARHGAP5 (mouse) LKQEHIRkRREEYIS K333-ub
ARHGAP5 iso3 (mouse) LKQEHIRKRREEYIS K333
ARHGAP5 (rat) LKQEHIRKRREEYIS K332
K394-ub
DETDHIDkINDRRIP
0 1
ARHGAP5 (human) DETDHIDkINDRRIP K394-ub
ARHGAP5 iso2 (human) DETDHIDKINDRRIP K394
ARHGAP5 (mouse) DETDHIDKINDRRIP K394
ARHGAP5 iso3 (mouse) DETDHIDKINDRRIP K394
ARHGAP5 (rat) DETDHIDKINDRRIP K393
T407
IPFDLLSTLEAEKVY
0 1
ARHGAP5 (human) IPFDLLSTLEAEKVY T407
ARHGAP5 iso2 (human) IPFDLLSTLEAEKVY T407
ARHGAP5 (mouse) IPFDLLStLEAEKVY T407-p
ARHGAP5 iso3 (mouse) IPFDLLSTLEAEKVY T407
ARHGAP5 (rat) IPFDLLSTLEAEKVY T406
K436
EMKEKFKKTLEKIQF
0 1
ARHGAP5 (human) EMKEKFKKTLEKIQF K436
ARHGAP5 iso2 (human) EMKEKFKKTLEKIQF K436
ARHGAP5 (mouse) EMKEKFKkTLEKIQF K436-ub
ARHGAP5 iso3 (mouse) EMKEKFKKTLEKIQF K436
ARHGAP5 (rat) EMKEKFKKTLEKIQF K435
K533-ub
PRYKALQkLAPDREs
0 1
ARHGAP5 (human) PRYKALQkLAPDREs K533-ub
ARHGAP5 iso2 (human) PRYKALQKLAPDRES K533
ARHGAP5 (mouse) PRYKALQKLAPDRES K533
ARHGAP5 iso3 (mouse) PRYKALQKLAPDRES K533
ARHGAP5 (rat) PRYKALQKLAPDRES K532
S540-p
kLAPDREsLLLKHIG
0 2
ARHGAP5 (human) kLAPDREsLLLKHIG S540-p
ARHGAP5 iso2 (human) KLAPDRESLLLKHIG S540
ARHGAP5 (mouse) KLAPDRESLLLKHIG S540
ARHGAP5 iso3 (mouse) KLAPDRESLLLKHIG S540
ARHGAP5 (rat) KLAPDRESLLLKHIG S539
S590-p
RLRLYHDstNIDKVN
0 8
ARHGAP5 (human) RLRLYHDstNIDKVN S590-p
ARHGAP5 iso2 (human) RLRLYHDSTNIDKVN S590
ARHGAP5 (mouse) RVRLYHDsTNIDKVN S590-p
ARHGAP5 iso3 (mouse) RVRLYHDSTNIDKVN S590
ARHGAP5 (rat) RSRLYHDSTNIDKVN S589
T591-p
LRLYHDstNIDKVNL
0 1
ARHGAP5 (human) LRLYHDstNIDKVNL T591-p
ARHGAP5 iso2 (human) LRLYHDSTNIDKVNL T591
ARHGAP5 (mouse) VRLYHDsTNIDKVNL T591
ARHGAP5 iso3 (mouse) VRLYHDSTNIDKVNL T591
ARHGAP5 (rat) SRLYHDSTNIDKVNL T590
K724-ub
QGQQLANkLQCPFVD
0 1
ARHGAP5 (human) QGQQLANkLQCPFVD K724-ub
ARHGAP5 iso2 (human) QGQQLANKLQCPFVD K724
ARHGAP5 (mouse) QGQQLANKLQCPFVD K724
ARHGAP5 iso3 (mouse) QGQQLANKLQCPFVD K724
ARHGAP5 (rat) QGQQLANKLQCPFVD K723
S765-p
KHNLDVVsPIPANKD
Upstream
0 22
Treatment
  • ischemia
  • MG132
  • nocodazole
ARHGAP5 (human) KHNLDVVsPIPANKD S765-p
ARHGAP5 iso2 (human) KHNLDVVSPIPANKD S765
ARHGAP5 (mouse) KHNLDVVsPVPINKD S765-p
ARHGAP5 iso3 (mouse) KHNLDVVSPVPINKD S765
ARHGAP5 (rat) KHNLDVVSPVPINKD S764
K858
YILVYSAKRKAsMGM
0 1
ARHGAP5 (human) YILVYSAKRKAsMGM K858
ARHGAP5 iso2 (human) YILVYSAKRKASMGM K858
ARHGAP5 (mouse) YILVYSAKRKASMGM K858
ARHGAP5 iso3 (mouse) YILVYSAkRKASMGM K858-ac
ARHGAP5 (rat) YILVYSAKRKASMGM K857
S862-p
YSAKRKAsMGMLRAF
Upstream
0 1
Treatment
  • MG132_withdrawal
ARHGAP5 (human) YSAKRKAsMGMLRAF S862-p
ARHGAP5 iso2 (human) YSAKRKASMGMLRAF S862
ARHGAP5 (mouse) YSAKRKASMGMLRAF S862
ARHGAP5 iso3 (mouse) YSAkRKASMGMLRAF S862
ARHGAP5 (rat) YSAKRKASMGMLRAF S861
S948-p
KKNMIENsYLsDNTR
0 1
ARHGAP5 (human) KKNMIENsYLsDNTR S948-p
ARHGAP5 iso2 (human) KKNMIENSYLSDNTR S948
ARHGAP5 (mouse) KKNMIENSYLSDNtR S948
ARHGAP5 iso3 (mouse) KKNMIENSYLSDNTR S948
ARHGAP5 (rat) KKNMIENSYLSDNTR S947
S951-p
MIENsYLsDNTREST
0 3
ARHGAP5 (human) MIENsYLsDNTREST S951-p
ARHGAP5 iso2 (human) MIENSYLSDNTREST S951
ARHGAP5 (mouse) MIENSYLSDNtREst S951
ARHGAP5 iso3 (mouse) MIENSYLSDNTREST S951
ARHGAP5 (rat) MIENSYLSDNTREST S950
T954
NsYLsDNTRESTHQS
0 1
ARHGAP5 (human) NsYLsDNTRESTHQS T954
ARHGAP5 iso2 (human) NSYLSDNTRESTHQS T954
ARHGAP5 (mouse) NSYLSDNtREstHQS T954-p
ARHGAP5 iso3 (mouse) NSYLSDNTRESTHQS T954
ARHGAP5 (rat) NSYLSDNTRESTHQS T953
S957
LsDNTRESTHQSEDV
0 1
ARHGAP5 (human) LsDNTRESTHQSEDV S957
ARHGAP5 iso2 (human) LSDNTRESTHQSEDV S957
ARHGAP5 (mouse) LSDNtREstHQSEDV S957-p
ARHGAP5 iso3 (mouse) LSDNTRESTHQSEDV S957
ARHGAP5 (rat) LSDNTRESTHQSEDV S956
T958
sDNTRESTHQSEDVF
0 1
ARHGAP5 (human) sDNTRESTHQSEDVF T958
ARHGAP5 iso2 (human) SDNTRESTHQSEDVF T958
ARHGAP5 (mouse) SDNtREstHQSEDVF T958-p
ARHGAP5 iso3 (mouse) SDNTRESTHQSEDVF T958
ARHGAP5 (rat) SDNTRESTHQSEDVF T957
S968-p
SEDVFLPsPRDCFPY
Upstream
0 19
Treatment
  • MLN8054
  • selumetinib
  • vemurafenib
ARHGAP5 (human) SEDVFLPsPRDCFPY S968-p
ARHGAP5 iso2 (human) SEDVFLPSPRDCFPY S968
ARHGAP5 (mouse) SEDVFLPsPRDCFPY S968-p
ARHGAP5 iso3 (mouse) SEDVFLPSPRDCFPY S968
ARHGAP5 (rat) SEDVFLPSPRDCFPY S967
S981-p
PYNNYPDsDDDTEAP
0 2
ARHGAP5 (human) PYNNYPDsDDDTEAP S981-p
ARHGAP5 iso2 (human) PYNNYPDSDDDTEAP S981
ARHGAP5 (mouse) PYNNYPDsDDDtEAP S981-p
ARHGAP5 iso3 (mouse) PYNNYPDSDDDTEAP S981
ARHGAP5 (rat) PYNNYPDSDDDTEAP S980
T985
YPDsDDDTEAPPPYS
0 1
ARHGAP5 (human) YPDsDDDTEAPPPYS T985
ARHGAP5 iso2 (human) YPDSDDDTEAPPPYS T985
ARHGAP5 (mouse) YPDsDDDtEAPPPYS T985-p
ARHGAP5 iso3 (mouse) YPDSDDDTEAPPPYS T985
ARHGAP5 (rat) YPDSDDDTEAPPPYS T984
Y1019-p
LDLEGNEyPIHStPN
0 13
ARHGAP5 (human) LDLEGNEyPIHStPN Y1019-p
ARHGAP5 iso2 (human) LDLEGNEYPIHSTPN Y1019
ARHGAP5 (mouse) LDLEGNEYPVHSTPN Y1019
ARHGAP5 iso3 (mouse) LDLEGNEYPVHSTPN Y1019
ARHGAP5 (rat) LDLEGNEYPVHSTPN Y1018
T1024-p
NEyPIHStPNCHDHE
0 1
ARHGAP5 (human) NEyPIHStPNCHDHE T1024-p
ARHGAP5 iso2 (human) NEYPIHSTPNCHDHE T1024
ARHGAP5 (mouse) NEYPVHSTPNCHDHE T1024
ARHGAP5 iso3 (mouse) NEYPVHSTPNCHDHE T1024
ARHGAP5 (rat) NEYPVHSTPNCHDHE T1023
K1053-ub
VPKTNVKkLDPNLLk
0 2
ARHGAP5 (human) VPKTNVKkLDPNLLk K1053-ub
ARHGAP5 iso2 (human) VPKTNVKKLDPNLLK K1053
ARHGAP5 (mouse) VPKTNVKKLDPNLLk K1053
ARHGAP5 iso3 (mouse) VPKTNVKKLDPNLLK K1053
ARHGAP5 (rat) VPKTNVKKLDPNLLK K1052
K1060-ub
kLDPNLLkTIEAGIG
0 2
ARHGAP5 (human) kLDPNLLkTIEAGIG K1060-ub
ARHGAP5 iso2 (human) KLDPNLLKTIEAGIG K1060
ARHGAP5 (mouse) KLDPNLLkTIEAGIG K1060-ub
ARHGAP5 iso3 (mouse) KLDPNLLKTIEAGIG K1060
ARHGAP5 (rat) KLDPNLLKTIEAGIG K1059
S1088-p
HPEDMDPsDNyAEPI
0 2
ARHGAP5 (human) HPEDMDPsDNyAEPI S1088-p
ARHGAP5 iso2 (human) HPEDMDPSDNYAEPI S1088
ARHGAP5 (mouse) HPEDMDSSDNYVEPL S1088
ARHGAP5 iso3 (mouse) HPEDMDSSDNYVEPL S1088
ARHGAP5 (rat) HPEDMDSSDNYAEPL S1087
Y1091-p
DMDPsDNyAEPIDTI
Upstream
1 119
Treatment
  • ephrin_B1
ARHGAP5 (human) DMDPsDNyAEPIDTI Y1091-p
ARHGAP5 iso2 (human) DMDPSDNYAEPIDTI Y1091
ARHGAP5 (mouse) DMDSSDNYVEPLDTI Y1091
ARHGAP5 iso3 (mouse) DMDSSDNYVEPLDTI Y1091
ARHGAP5 (rat) DMDSSDNYAEPLDTI Y1090
K1100
EPIDTIFKQkGysDE
0 1
ARHGAP5 (human) EPIDTIFKQkGysDE K1100
ARHGAP5 iso2 (human) EPIDTIFKQKGYSDE K1100
ARHGAP5 (mouse) EPLDTIFkQkGYsDE K1100-ub
ARHGAP5 iso3 (mouse) EPLDTIFKQKGYSDE K1100
ARHGAP5 (rat) EPLDTIFKQKGYPDE K1099
K1102-ub
IDTIFKQkGysDEIy
0 2
ARHGAP5 (human) IDTIFKQkGysDEIy K1102-ub
ARHGAP5 iso2 (human) IDTIFKQKGYSDEIY K1102
ARHGAP5 (mouse) LDTIFkQkGYsDEIy K1102-ub
ARHGAP5 iso3 (mouse) LDTIFKQKGYSDEIY K1102
ARHGAP5 (rat) LDTIFKQKGYPDEIy K1101
Y1104-p
TIFKQkGysDEIyVV
Upstream
0 4
Treatment
  • Su11274
ARHGAP5 (human) TIFKQkGysDEIyVV Y1104-p
ARHGAP5 iso2 (human) TIFKQKGYSDEIYVV Y1104
ARHGAP5 (mouse) TIFkQkGYsDEIyVV Y1104
ARHGAP5 iso3 (mouse) TIFKQKGYSDEIYVV Y1104
ARHGAP5 (rat) TIFKQKGYPDEIyVV Y1103
S1105-p
IFKQkGysDEIyVVP
0 4
ARHGAP5 (human) IFKQkGysDEIyVVP S1105-p
ARHGAP5 iso2 (human) IFKQKGYSDEIYVVP S1105
ARHGAP5 (mouse) IFkQkGYsDEIyVVP S1105-p
ARHGAP5 iso3 (mouse) IFKQKGYSDEIYVVP S1105
ARHGAP5 (rat) IFKQKGYPDEIyVVP P1104
Y1109-p
kGysDEIyVVPDDsQ
Upstream
Downstream
2 181
Effects on Modified Protein
  • activity, induced
Effects on Biological Processes:
  • cell growth, altered
  • cell motility, altered
Kinase, in vitro:
  • Brk (human)
Putative in vivo kinases:
  • Brk (human)
  • Src (human)
Treatment
  • ephrin_B1
  • ephrin_B2
  • gefitinib
  • Su11274
ARHGAP5 (human) kGysDEIyVVPDDsQ Y1109-p
ARHGAP5 iso2 (human) KGYSDEIYVVPDDSQ Y1109
ARHGAP5 (mouse) kGYsDEIyVVPDDSQ Y1109-p
ARHGAP5 iso3 (mouse) KGYSDEIYVVPDDSQ Y1109
ARHGAP5 (rat) KGYPDEIyVVPDDSQ Y1108-p
S1115-p
IyVVPDDsQNRIKIR
Upstream
0 7
Treatment
  • BI2536
ARHGAP5 (human) IyVVPDDsQNRIKIR S1115-p
ARHGAP5 iso2 (human) IYVVPDDSQNRIKIR S1115
ARHGAP5 (mouse) IyVVPDDSQNRIIKI S1115
ARHGAP5 iso3 (mouse) IYVVPDDSQNRIIKI S1115
ARHGAP5 (rat) IyVVPDDSQNRIIKI S1114
S1124-p
NRIKIRNsFVNNtQG
Upstream
0 50
Treatment
  • BI2536
  • MLN8054
  • selumetinib
  • vemurafenib
ARHGAP5 (human) NRIKIRNsFVNNtQG S1124-p
ARHGAP5 iso2 (human) NRIKIRNSFVNNTQG S1124
ARHGAP5 (mouse) RIIKIRNSFVNNTQG S1125
ARHGAP5 iso3 (mouse) RIIKIRNsFVNNTQG S1125-p
ARHGAP5 (rat) RIIKIRNSFVNNTQG S1124
T1129-p
RNsFVNNtQGDEENG
Upstream
0 19
Treatment
  • BI2536
  • MLN8054
ARHGAP5 (human) RNsFVNNtQGDEENG T1129-p
ARHGAP5 iso2 (human) RNSFVNNTQGDEENG T1129
ARHGAP5 (mouse) RNSFVNNTQGDEENG T1130
ARHGAP5 iso3 (mouse) RNsFVNNTQGDEENG T1130
ARHGAP5 (rat) RNSFVNNTQGDEENG T1129
S1138-p
GDEENGFsDRTSKSH
Upstream
0 5
Treatment
  • BI2536
  • MLN8054
ARHGAP5 (human) GDEENGFsDRTSKSH S1138-p
ARHGAP5 iso2 (human) GDEENGFSDRTSKSH S1138
ARHGAP5 (mouse) GDEENGFSDPQKVME S1139
ARHGAP5 iso3 (mouse) GDEENGFSDRTSKGH S1139
ARHGAP5 (rat) GDEENGFSDRTSKGH S1138
T1159-p
KYKYKSKtLFSKAKS
0 1
ARHGAP5 (human) KYKYKSKtLFSKAKS T1159-p
ARHGAP5 iso2 (human) KYKYKSKTLFSKAKS T1159
ARHGAP5 (mouse) gap -
ARHGAP5 iso3 (mouse) KYKYKSKTLFSKAKS T1160
ARHGAP5 (rat) KYKYKSKTLFSKAKS T1159
T1171-p
AKSYYRRtHsDAsDD
Upstream
0 7
Treatment
  • angiotensin_2
ARHGAP5 (human) AKSYYRRtHsDAsDD T1171-p
ARHGAP5 iso2 (human) AKSYYRRTHSDASDD T1171
ARHGAP5 (mouse) gap -
ARHGAP5 iso3 (mouse) AKSYYRRTHsDAsDD T1172
ARHGAP5 (rat) AKSYYRRTHsDAsDD T1171
S1173-p
SYYRRtHsDAsDDEA
Upstream
0 50
Treatment
  • angiotensin_2
  • BI2536
  • ischemia
ARHGAP5 (human) SYYRRtHsDAsDDEA S1173-p
ARHGAP5 iso2 (human) SYYRRTHSDASDDEA S1173
ARHGAP5 (mouse) gap -
ARHGAP5 iso3 (mouse) SYYRRTHsDAsDDEA S1174-p
ARHGAP5 (rat) SYYRRTHsDAsDDEA S1173-p
S1176-p
RRtHsDAsDDEAFTT
Upstream
0 53
Treatment
  • angiotensin_2
  • BI2536
ARHGAP5 (human) RRtHsDAsDDEAFTT S1176-p
ARHGAP5 iso2 (human) RRTHSDASDDEAFTT S1176
ARHGAP5 (mouse) gap -
ARHGAP5 iso3 (mouse) RRTHsDAsDDEAFTT S1177-p
ARHGAP5 (rat) RRTHsDAsDDEAFPT S1176-p
S1184-p
DDEAFTTsKTKRKGR
Upstream
0 1
Treatment
  • MLN8054
ARHGAP5 (human) DDEAFTTsKTKRKGR S1184-p
ARHGAP5 iso2 (human) DDEAFTTSKTKRKGR S1184
ARHGAP5 (mouse) gap -
ARHGAP5 iso3 (mouse) DDEAFTTSKTKRKGR S1185
ARHGAP5 (rat) DDEAFPTSKTKRKGR S1184
S1195-p
RKGRHRGsEEDPLLs
Upstream
0 37
Regulatory protein:
  • TBK1 (human)
Treatment
  • angiotensin_2
  • BI_4834
  • EGF
  • ischemia
  • SB202190
  • selumetinib
  • vemurafenib
ARHGAP5 (human) RKGRHRGsEEDPLLs S1195-p
ARHGAP5 iso2 (human) RKGRHRGSEEDPLLS S1195
ARHGAP5 (mouse) RKGRHRGsEEDPLLs S1194-p
ARHGAP5 iso3 (mouse) RKGRHRGSEEDPLLS S1196
ARHGAP5 (rat) RKGRHRGsEEDPLLs S1195-p
S1202-p
sEEDPLLsPVEtWKG
Upstream
0 34
Treatment
  • angiotensin_2
  • BI_4834
  • EGF
  • ischemia
  • metastatic potential
  • SB202190
  • selumetinib
  • vemurafenib
ARHGAP5 (human) sEEDPLLsPVEtWKG S1202-p
ARHGAP5 iso2 (human) SEEDPLLSPVETWKG S1202
ARHGAP5 (mouse) sEEDPLLsPVETWkG S1201-p
ARHGAP5 iso3 (mouse) SEEDPLLSPVETWKG S1203
ARHGAP5 (rat) sEEDPLLsPVETWKG S1202-p
T1206-p
PLLsPVEtWKGGIDN
0 2
ARHGAP5 (human) PLLsPVEtWKGGIDN T1206-p
ARHGAP5 iso2 (human) PLLSPVETWKGGIDN T1206
ARHGAP5 (mouse) PLLsPVETWkGGIDN T1205
ARHGAP5 iso3 (mouse) PLLSPVETWKGGIDN T1207
ARHGAP5 (rat) PLLsPVETWKGGIDN T1206
K1208
LsPVEtWKGGIDNPA
0 1
ARHGAP5 (human) LsPVEtWKGGIDNPA K1208
ARHGAP5 iso2 (human) LSPVETWKGGIDNPA K1208
ARHGAP5 (mouse) LsPVETWkGGIDNPA K1207-ub
ARHGAP5 iso3 (mouse) LSPVETWKGGIDNPA K1209
ARHGAP5 (rat) LsPVETWKGGIDNPA K1208
T1217-p
GIDNPAItsDQELDD
0 4
ARHGAP5 (human) GIDNPAItsDQELDD T1217-p
ARHGAP5 iso2 (human) GIDNPAITSDQELDD T1217
ARHGAP5 (mouse) GIDNPAItsDQEVDD T1216-p
ARHGAP5 iso3 (mouse) GIDNPAITSDQEVDD T1218
ARHGAP5 (rat) GIDNPAITsDQEVDD T1217
S1218-p
IDNPAItsDQELDDK
0 48
ARHGAP5 (human) IDNPAItsDQELDDK S1218-p
ARHGAP5 iso2 (human) IDNPAITSDQELDDK S1218
ARHGAP5 (mouse) IDNPAItsDQEVDDK S1217-p
ARHGAP5 iso3 (mouse) IDNPAITSDQEVDDK S1219
ARHGAP5 (rat) IDNPAITsDQEVDDK S1218-p
K1243
EDKKQKKKTKNFNPP
0 1
ARHGAP5 (human) EDKKQKKKTKNFNPP K1243
ARHGAP5 iso2 (human) KEDKKKKKTKNFNPP K1242
ARHGAP5 (mouse) EDKKQKKkTKTFNPP K1242-ac
ARHGAP5 iso3 (mouse) EDKKQKKKTKTFNPP K1244
ARHGAP5 (rat) gap -
Y1259
RRNWESNYFGMPLQD
0 1
ARHGAP5 (human) RRNWESNYFGMPLQD Y1259
ARHGAP5 iso2 (human) RRNWESNYFGMPLQD Y1258
ARHGAP5 (mouse) RRNWESNyFGMPLQD Y1258-p
ARHGAP5 iso3 (mouse) RRNWESNYFGMPLQD Y1260
ARHGAP5 (rat) gap -
K1272
QDLVTAEKPIPLFVE
0 1
ARHGAP5 (human) QDLVTAEKPIPLFVE K1272
ARHGAP5 iso2 (human) QDLVTAEKPIPLFVE K1271
ARHGAP5 (mouse) QDLVTAEkPIPLFVE K1271-ac
ARHGAP5 iso3 (mouse) QDLVTAEKPIPLFVE K1273
ARHGAP5 (rat) gap -
S1396-p
ITHLNRVsQQHKINL
0 1
ARHGAP5 (human) ITHLNRVsQQHKINL S1396-p
ARHGAP5 iso2 (human) ITHLNRVSQQHKINL S1395
ARHGAP5 (mouse) ITHLNRVSQQNKINL S1395
ARHGAP5 iso3 (mouse) ITHLNRVSQQNKINL S1397
ARHGAP5 (rat) gap -